edifoligide

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2015
02420052015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Edifoligide, an E2F transcription factor decoy, does not prevent vein graft failure or adverse clinical outcomes at 1… (More)
  • figure 1
  • figure 2
  • table I
  • table II
Is this relevant?
2008
2008
OBJECTIVE Evidence suggesting a beneficial effect of cardioprotective medications in patients with lower extremity… (More)
Is this relevant?
2008
2008
BACKGROUND This analysis compares 1-year vein graft patency and major adverse cardiac and cerebral events (MACCE [death… (More)
Is this relevant?
2008
2008
Myocardial infarction (MI) after coronary artery bypass grafting (CABG) is associated with significant morbidity and mortality… (More)
Is this relevant?
Review
2007
Review
2007
The era of genomics and recombinant DNA technology has ushered in an entirely new class of therapeutic agents designed to… (More)
Is this relevant?
2006
2006
Vein graft neointimal hyperplasia involves proliferation and migration of vascular smooth muscle cells into the vessel intima… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2006
Review
2006
OBJECTIVE The PREVENT III study was a prospective, randomized, double-blinded, multicenter phase III trial of a novel molecular… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
CONTEXT Coronary artery bypass graft (CABG) surgery with autologous vein grafting is commonly performed. Progressive neointimal… (More)
Is this relevant?
2005
2005
Surgical bypass of peripheral arterial occlusive disease with autologous vein grafts provides an effective means of restoring… (More)
Is this relevant?
2005
2005
BACKGROUND Coronary artery bypass graft (CABG) surgery with autologous vein graft (VG) conduit is one of the most frequently… (More)
Is this relevant?